Literature DB >> 4029347

Plasmodium vinckei: suppression of mouse infections with desferrioxamine B.

G Fritsch, J Treumer, D T Spira, A Jung.   

Abstract

Plasmodium vinckei kills NMRI mice within 6 days after infection. Treatment of infected animals with desferrioxamine B for 5 days was found to suppress the parasitemia in a dose-dependent manner. The desferrioxamine B-iron complex (DFO/Fe3+) was ineffective, which suggests that the iron-chelating capacity of free desferrioxamine B is the antimalarial principle. All mice survived when they were given 0.3 mg desferrioxamine B/g every 12 hr for 14 days after infection. In addition, they were resistant to reinfection for at least 8 weeks. Eight months after desferrioxamine B treatment, all mice had lost their induced immunity and were as susceptible to malaria as controls. These results illustrate the dependence of the malarial parasite on ionic iron and suggests new methods for the therapy of parasitic diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029347     DOI: 10.1016/0014-4894(85)90020-7

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  16 in total

1.  In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.

Authors:  Bruno Pradines; Florence Ramiandrasoa; Jean Marc Rolain; Christophe Rogier; Joel Mosnier; William Daries; Thierry Fusai; Gerhard Kunesch; Jacques Le Bras; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.

Authors:  Asikiya Walcourt; Joseph Kurantsin-Mills; John Kwagyan; Babafemi B Adenuga; Danuta S Kalinowski; David B Lovejoy; Darius J R Lane; Des R Richardson
Journal:  J Inorg Biochem       Date:  2013-08-26       Impact factor: 4.155

3.  Chemical Determinants of antimalarial activity of reversed siderophores.

Authors:  A Tsafack; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 4.  Iron and infection.

Authors:  C Hershko; T E Peto; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

5.  Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.

Authors:  J Golenser; A Tsafack; Y Amichai; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.

Authors:  Chloé Latour; Myriam F Wlodarczyk; Grace Jung; Aurélie Gineste; Nicolas Blanchard; Tomas Ganz; Marie-Paule Roth; Hélène Coppin; Léon Kautz
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

7.  14C-desferrioxamine B: uptake into erythrocytes infected with Plasmodium falciparum.

Authors:  G Fritsch; A Jung
Journal:  Z Parasitenkd       Date:  1986

8.  Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia.

Authors:  A B Clarkson; M Sarić; R W Grady
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

9.  The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.

Authors:  M Loyevsky; S D Lytton; B Mester; J Libman; A Shanzer; Z I Cabantchik
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Iron chelators as therapeutic agents against Pneumocystis carinii.

Authors:  G A Weinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.